Skip to main content
. 2023 Apr 1;39:1–6. doi: 10.1016/j.jor.2023.03.013

Table 2.

Complications by CKD stage within OA.

Complication OA alone (N = 4,246,648a) Stage 1 (eGFR> 90 mL/min/1.73 m2) (N = 2176) Stage 2 (eGFR 60–89 mL/min/1.73 m2) (N = 13,458) Stage 3 (eGFR 30–59 mL/min/1.73 m2) (N = 69,601) Stage 4 (eGFR 15–29 mL/min/1.73 m2) (N = 9907) Stage 5 (eGFR< 15 mL/min/1.73 m2) (N = 817) P-Valueb
Wound seroma or hematoma 32491 (0.8%) 20 (0.9%) 74 (0.5%) 752 (1.1%) 178 (1.8%) 20 (2.4%) 0.0001
Wound infection 15044 (0.4%) 5 (0.2%) 94 (0.7%) 323 (0.5%) 54 (0.5%) 0 (0.0%) <0.0001
Dislocation 32392 (0.8%) 41 (1.9%) 163 (1.2%) 889 (1.3%) 175 (1.8%) 10 (1.2%) <0.0001
Cardiac complications 27224 (0.6%) 27 (1.3%) 97 (0.7%) 856 (1.2%) 113 (1.1%) 4 (0.5%) <0.0001
Urinary complications 85854 (2.0%) 192 (8.8%) 1507 (11.2%) 11996 (17.2%) 3036 (30.6%) 210 (25.7%) <0.0001
Pulmonary complications 21631 (0.5%) 8 (0.4%) 307 (2.3%) 1243 (1.8%) 268 (2.7%) 30 (3.7%) <0.0001
a

Sample size based on weighted frequencies, rounded to the nearest whole integer.

b

p-value from Rao-Scott chi-square test adjusted for sampling weights and design.